notablelabs.com - נכסים נקיים למניה בודדת NTBL
Notable Labs, Ltd. (NTBL) is actively scaling its precision oncology system to predict drug efficacy. This historical book value chart illustrates capital dynamics, where 0.74 represents the current metric. The company creates a competitive advantage through AI-driven live-cell screening and unique patents. Diagnostic reliability is ensured by strict temperature control during the express delivery of biomaterials to laboratories.
פילוחי נתונים אנליטיים מרוכזים עבור notablelabs.com (NTBL)
To find a balance between asset quality and market price, it is essential for an investor to understand the company's net assets per share, which determines the business's resilience to external shocks. This book value per share reflects the capitalization of the Notable Labs, Ltd. (NTBL) technological platform for blood cancer therapy selection, demonstrating the real value of the resources deployed in creating innovative diagnostic solutions.